FP Partner Inc. Q4 FY2024 earnings call

• Overall 2024 Full-Year Financial Results

  • Total revenue reached 35.617 billion yen, up 16.6% year-over-year, hitting 99.97% of the revised full-year forecast. Operating profit came in at 5.33 billion yen, down 4% year-over-year, hitting 88.7% of forecast; net profit was 3.903 billion yen, down 1.3% year-over-year, hitting 94.21% of forecast.
  • Key KPIs all hit record highs: sales staff exceeded 2,500 for the first time at 2,518, up 8.3% YoY; prospective customers hit 163,306, up 8.8% YoY; total new contracts hit 250,396, up 10.4% YoY; in-force contracts grew 19.1% YoY net to 1.73 million, and in-force customers grew 14.4% YoY net. 681 new sales staff were hired in 2024 (a company record), and 22 new branch locations were added.

• Causes of Operating Profit Miss vs Forecast

  • First, higher sales staff compensation rates to recruit top performers from competitors increased cost of goods sold, with this upfront investment expected to drive revenue and profit growth starting from 2025.
  • Second, product portfolio shift: higher customer demand for lump-sum payment investment-focused products drove higher sales of these lower-margin products, while lower sales of higher-margin regular-payment protection products reduced total quality support income by 650 million yen in Q4 alone. The June 2024 press reports related to the Financial Services Agency inspection also reduced sales team morale, leading to lower proactive outreach for protection products, further worsening the portfolio mix.

• Strategic Growth Priorities (2025-2027)

  • Shift from three core growth pillars to a DX + education-based growth foundation to improve overall operational efficiency and staff skill level standardization.
  • Expand contract transfer business to 100,000 annual transfers in 2025, target 1 billion yen in new premium from additional contracts with transferred customers, and scale long-term to 150,000-200,000 annual transfers.
  • Expand Maneedo Doctor Premier to 50 total stores by 2026, targeting 2.5 billion yen in new annual premium in 2025.
  • Expand IFA business to maximize customer lifetime value by adding investment trusts, bonds, and mortgage products alongside insurance offerings.
  • Prioritize shareholder returns by introducing progressive dividend policy, commit to paying dividends higher than the prior period every year. In 2024, the company paid 92 yen per share total dividend, conducted two 1 billion yen share repurchases, and projects 94 yen per share total dividend for 2025.
  • Capital allocation: Project 12 billion yen in total free cash flow over the 3-year medium-term plan, hold 9 billion yen in cash on hand, prioritize shareholder returns, contract transfer expansion, M&A, DX investment, and human capital investment, maintain strong balance sheet with minimal debt.

FP Partner operates across multiple core business segments focused on financial and insurance services: 1. Core Life Insurance Agency: Revenue contributed the majority of total 35.617 billion yen full-year sales. Total stock recurring commission from existing in-force policies exceeded 5.355 billion yen, growing steadily from prior periods. Life insurance fee revenue saw a sharp drop in Q4 2024 due to lower quality support income, but showed recovery signs in the first quarter of 2025. 2. Contract Transfer Business: This high-margin segment delivered strong growth, with 94,509 agreed transfer contracts in 2024, up 87.3% year-over-year. Additional new premium from transferred customers reached 676.123 million yen in 2024, up from 87.413 million yen in 2021, with 60-70% of agency fees converting to profit. 3. Maneedo Doctor Premier: Reached its 3-year target of 30 store locations in 2024, with 7,529 total customer consultations, and generated 2.009 billion yen in new annual premium. 4. Non-Life Insurance: Began contract transfer expansion in 2024, securing 47,221 agreed transfer contracts, with projected 1.381 billion yen in fee revenue for 2025. 5. IFA Business: Launched in 2024 alongside new NISA, accumulated 6,738 customer accounts and 25.931 billion yen in assets under management by end-2024, expanding to 76 IFA offices and 783 sales staff. 6. Financial Literacy Education: New business that reached 6 corporate implementations and 778 total trainees in 2024, with the advertising business discontinued in July 2024.

• 2025 November Fiscal Year guidance: Revenue of 40.232 billion yen, up 13% year-over-year; operating profit of 6.13 billion yen, up 15% year-over-year; net profit of 4.041 billion yen. This guidance is set as a lower bound, and management will work to achieve an upward revision by year-end.
• 3-year (2025-2027) rolling medium-term plan targets: 2027 full-year revenue of at least 52.664 billion yen, operating profit of 9.196 billion yen, net profit of 6.15 billion yen.
• The 2025 plan is intentionally moderately conservative, as full recovery from 2024's profit decline is expected to take approximately one full year, with more material margin improvement projected starting from 2026.
• Contract transfer business target of 100,000 annual transfers in 2025, with 1 billion yen in new annual premium from additional contracts with transferred customers. Maneedo Doctor Premier targets 2.5 billion yen in new annual premium in 2025. Non-life insurance fee revenue is projected to reach 1.381 billion yen in 2025.

• In Q4 2024, press reports of a Financial Services Agency inspection reduced sales team morale, leading to lower outreach for high-margin protection products, causing a 650 million yen drop in quality support income and operating profit miss relative to forecast.
• The shift in customer demand toward lump-sum investment products has reduced the share of higher-margin regular-payment protection products, pressuring overall operating margin.
• Higher sales staff compensation for new recruited top performers increased near-term costs, with profit contributions from these new hires not expected to materialize until 2025 and beyond.

Q: What was the impact of the June 2024 press reports about the FSA inspection, and what is the current status? / A: Management declined to comment on the status of the inspection itself. There were almost no customer complaints and no negative pushback from partner businesses following the reports. The main impact was reduced sales team morale, which led to less proactive outreach for high-margin protection products in the August-October period of Q4. The company has already followed up to re-educate affected customers and restarted protection product sales, and sales of these products have already recovered in the first quarter of 2025.

Q: Why did sales of high-margin products decline, and what are these high-margin products? / A: High-margin products that generate higher quality support income are primarily protection-focused products like death cover and medical insurance, while lump-sum payment investment products generate far lower quality support income. The 2024 decline in protection product sales was primarily due to the press report impact on sales team outreach, which led to fewer proactive consultations for protection needs, combined with a natural market shift toward investment products driven by customer demand. Management views this as a temporary, short-term factor and has already taken corrective actions for 2025.

Q: Why change the dividend policy to progressive dividend, and what is the underlying reasoning? / A: The company already generates abundant free cash flow and stable recurring stock revenue, and has maintained a payout ratio above 50% in the last two years even with the 45% target payout ratio, proving it can balance growth investment and shareholder returns. The company introduced progressive dividend policy to commit publicly to continuously increasing dividends year-over-year for the long term, which clarifies its strong commitment to shareholder return as a core policy.

Q: What is the future outlook for contract transfer business, which is your key growth focus? / A: The business entered its fifth year in 2025, after beating target with 94,000 transfers in 2024. As regulatory requirements for insurance agencies tighten, more small agencies are exiting the market, creating strong tailwinds for FP Partner to acquire transferred contracts, including from listed companies exiting insurance operations. The company has a proven process to assign dedicated FPs to transferred customers, and new additional contracts from these customers are now generated reliably 3 months after transfer, with much higher margins than new customer acquisition from partner channels. Long-term, the business can scale to 150,000-200,000 transfers per year and will become a core long-term growth pillar for the company.

Q: Can you achieve the 13% 2025 revenue growth target with only 8% sales staff growth, and why is the margin improvement so small? / A: The 13% growth target is achievable because recent new hires are higher-quality top performers from other industry players, which drives higher average productivity than historical hires, and the company has consistently delivered over 5 billion yen in annual revenue growth for multiple years with no major blocking factors. The small projected margin improvement is due to the lingering impact of 2024's weak performance; while corrective actions have been taken, full margin recovery will take approximately one full year, so management set a conservative 2025 target to deliver against, with larger margin improvements planned for 2026 and beyond.